Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder.
about
Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in childrenOmega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature DataThe Essentiality of Arachidonic Acid in Infant DevelopmentNatural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination TherapyN-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyThe Δ4-desaturation pathway for DHA biosynthesis is operative in the human species: differences between normal controls and children with the Zellweger syndromeMS/MS analysis and imaging of lipids across Drosophila brain using secondary ion mass spectrometry.Effectiveness of methylphenidate and PUFA for the treatment of patients with ADHD: A double-blinded randomized clinical trial.Developmental effects of dietary n-3 fatty acids on activity and response to novelty.Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study--a randomized controlled trial.Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.Suboptimal Plasma Long Chain n-3 Concentrations are Common among Adults in the United States, NHANES 2003-2004.A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 yearDocosahexaenoic acid and cognitive function: Is the link mediated by the autonomic nervous system?Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled studyRole of docosahexaenoic acid in maternal and child mental health.Neuron membrane trafficking and protein kinases involved in autism and ADHD.Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies.Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
P2860
Q24644491-9D75FA2A-E335-46F6-9BBD-3E4953BE8588Q24681087-641D239F-C63C-43F0-9525-8A4E0404FD9AQ26740508-6F10925F-DDD9-4010-AEF5-484B1FED4621Q26748375-529F4328-4C59-44D8-B2BB-24EFB843A763Q26766330-DAC3796F-878A-42F8-A4F0-8B5EC37F37F9Q28072641-1E754FE3-073A-4AFA-8B83-0853D52564EAQ33688532-54C7EFAE-F94E-40CC-B0F8-638603F5ACEFQ33705331-B2939EE5-C718-4F68-8565-4F65EDD712E5Q33876133-9296477F-168D-49D8-AAC8-82CB3EBF2533Q34072669-8FD3EE8F-F04F-4A50-B1E2-4AE2E6F5DD30Q34677771-17DA09E9-6972-4664-934B-7A36D8AD91F9Q35670890-85CE1F86-DB06-4252-99B5-917B0F4816D0Q35981290-97888C8B-3742-4C56-8F72-71BF2C52EDCDQ36401339-063CAF43-3AB3-4A9C-A36B-B58EB278BD1EQ37053396-5319F7D8-82C0-4819-9888-19A1BAB8392EQ37115632-F18B8193-FCD4-4790-B698-1D53EC0404A0Q37141442-57F05295-691A-4636-9774-64F3F4D8AEA5Q37155207-C5001264-B96E-4BAC-964C-81D3F03B8F2AQ38342576-C560B419-E87F-45D8-8C49-69FC074A7107Q39457006-54449F74-863E-46C0-B32D-4D276A7DA93FQ41987116-2AFFE1E2-9982-40CC-B821-348AF3A6BDBA
P2860
Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@ast
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@en
type
label
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@ast
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@en
prefLabel
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@ast
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@en
P2093
P356
P1476
Long-chain polyunsaturated fat ...... eficit hyperactivity disorder.
@en
P2093
P304
P356
10.1093/AJCN/71.1.327S
P407
P433
P577
2000-01-01T00:00:00Z